SOTU Psychosis in the Press, and the USA Hockey Team Continues to Enrage...
Joy Behar Thinks the SAVE Act Will Help Republicans Cheat in November
The Left Wants a Nuclear Family Meltdown
Tim Walz's Paid Medical and Family Leave Law Is Already Being Abused
Grand Rapids Mayor: People Should Be Made to Feel Shame for Having Guns
The Legendary Ending to President Trump's State of the Union
President Trump Just Responded to Ilhan Omar and Rashida Tlaib's Outbursts at the...
Mamdani's NYC Flirts With Chaos
Dearborn Heights Man Pleads Guilty to $3.2 Million Healthcare Scheme
Texas Orthopedic Surgeon Sentenced to 8.5 Years in $145M Healthcare Scheme
U.S. Supreme Court Hears Challenge to Michigan County’s $2,242 Tax Foreclosure on $194k...
Sen. Moreno Tries to Advance Bill to Stop Welfare Recipients From Sending Money...
Feds Freeze $259M in Medicaid Funds to Minnesota Over Alleged Fraud
Florida Man Sentenced to 6 Years in Nationwide Bank Fraud Scheme
Memphis Woman Sentenced to Federal Prison for $560K COVID-19 Fraud Across 20 States
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos